Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.

CONCLUSION: Mifepristone combined with misoprostol is, overall, more cost effective than monotherapy, and therefore cost should not be a deterrent to its adoption in the management of miscarriage.
PMID: 32925621 [PubMed - as supplied by publisher]

Source: Obstetrics and Gynecology - September 9, 2020 Category: OBGYN Authors: Berkley HH, Greene HL, Wittenberger MD Tags: Obstet Gynecol Source Type: research